CVS Health Inc. (NYSE:CVS) outlined its future growth plans at its investor day on Tuesday. CVS Health stock is charging ahead with explosive momentum. Why is CVS stock surging? Raising Fiscal 2025 Ou[...]
Read more
Articles written by Vandana Singh
Could This Eli Lilly Oral Pill Be Key To Significant Weight Loss?
Eli Lilly and Co (NYSE:LLY) on Tuesday shared detailed results from the Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of oral orforglipron in adults with obesity, or overweight with a wei[...]
Read more
Achieve Life Sciences Inches Closer To FDA Nod For First New Quit-Smoking Drug In 20 Years
Achieve Life Sciences Inc. (NASDAQ:ACHV) is moving closer to a pivotal moment as it seeks FDA approval for cytisinicline, a potential first new smoking cessation therapy in nearly two decades, positio[...]
Read more
AstraZeneca’s Drug Shows Promise For Resistant Hypertension In Phase 3 Trial
AstraZeneca Plc (NASDAQ:AZN) on Monday released topline data from the BaxHTN Phase 3 trial of baxdrostat in patients with uncontrolled or treatment-resistant hypertension. The trial included patients[...]
Read more